Enhancing Collaborations between Private Medical Institutions and MoHAP for the Progression of the National Neonatal Screening Initiative
The United Arab Emirates (UAE) Ministry of Health and Prevention (MoHAP) has launched a comprehensive National Newborn Screening Programme to detect genetic, hereditary, and critical health conditions in newborns. The programme, which follows strict protocols and standards mandated by federal health legislation and a UAE Cabinet Resolution, includes several key components.
Blood Sample Collection and Testing
Newborns undergo blood sample collection for biochemical testing at the National Reference Laboratory. This process helps identify metabolic, genetic, and other conditions that may not be immediately apparent.
Hearing and Cardiac Assessments
The programme also includes hearing assessments to detect early hearing impairments and cardiac screenings aimed at identifying critical congenital heart defects before symptoms appear.
Digital Healthcare Platform Integration
The 'Riayati' digital healthcare platform plays a significant role in the initiative. This platform integrates patient data from public and private hospitals into a unified national medical record system, enhancing automation, accuracy, clinical decision-making, and patient safety.
Nationwide Implementation and Continuous Improvement
The programme operates through a unified hospital network nationwide, including private hospital partnerships, and is continuously updated to incorporate evolving international best practices and additional screening tests as needed.
Abu Dhabi's Newborn Genetic Screening Programme
In Abu Dhabi, the Department of Health (DoH) has launched a cutting-edge Newborn Genetic Screening Programme. This initiative offers whole genome sequencing for screening over 815 treatable childhood genetic conditions, making it one of the most comprehensive genomic screening efforts worldwide. The programme currently operates in select hospitals and plans gradual expansion throughout the emirate.
Emphasis on Early Detection and Prevention
These protocols emphasize early detection through standardized biochemical, hearing, cardiac, and advanced genetic testing integrated within national healthcare IT infrastructure. The aim is to make newborn health screening a strategic priority for UAE health authorities, enhancing patient safety, improving efficiency, and supporting informed clinical decision-making.
Private Hospitals as Strategic Partners
The Ministry of Health and Prevention (MoHAP) continues to highlight the critical role of private hospitals in achieving national healthcare objectives. Private hospitals are identified as strategic partners in this initiative, working towards a standardized approach for early detection and prevention of complications.
The programme follows strict procedures, standards, and regulatory frameworks defined by the Health Regulation Sector, ensuring consistent application of screening protocols across public and private facilities. This collaborative approach underscores the UAE's commitment to safeguarding newborn health, a strategic national priority as emphasized by MoHAP.
[1] Source: UAE Ministry of Health and Prevention [2] Source: National Newborn Screening Programme [3] Source: Riayati Digital Healthcare Platform [4] Source: Department of Health, Abu Dhabi
- To ensure the well-being of newborns, the National Newborn Screening Programme in the UAE, backed by strict protocols, incorporates biochemical testing, hearing assessments, cardiac screenings, and advanced genetic testing for early detection of numerous health-related conditions, operating nationwide with the support of private hospitals.
- Embracing science and medical advancements, Abu Dhabi's Newborn Genetic Screening Programme offers whole genome sequencing, enabling the detection of over 800 treatable genetic conditions, setting a high standard in health and wellness for newborns, with plans to expand the programme throughout the emirate.
